A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
Inclusion Criteria
- Have provided written informed consent
- Be at least 18 years of age
- Have dry eye in both eyes
- Have provided written informed consent
- Be at least 18 years of age
- Have dry eye in both eyes
Exclusion Criteria
- Have an uncontrolled systemic disease
- Have an uncontrolled psychiatric condition, or substance or alcohol abuse
- Women who is pregnant, nursing or planning a pregnancy
- ...
- Have an uncontrolled systemic disease
- Have an uncontrolled psychiatric condition, or substance or alcohol abuse
- Women who is pregnant, nursing or planning a pregnancy
- Use of contact lenses
Summary
- Conditions
- Dry Eye Syndromes
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Inclusion Criteria
- Have provided written informed consent
- Be at least 18 years of age
- Have dry eye in both eyes
- Have provided written informed consent
- Be at least 18 years of age
- Have dry eye in both eyes
Exclusion Criteria
- Have an uncontrolled systemic disease
- Have an uncontrolled psychiatric condition, or substance or alcohol abuse
- Women who is pregnant, nursing or planning a pregnancy
- ...
- Have an uncontrolled systemic disease
- Have an uncontrolled psychiatric condition, or substance or alcohol abuse
- Women who is pregnant, nursing or planning a pregnancy
- Use of contact lenses
Tracking Information
- NCT #
- NCT02205840
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon